This is a routine director-level sale tied to equity compensation vesting. No material signal for the stock. Monitor for any acceleration of insider selling patterns, but this filing alone does not warrant action.
Price Chart
Executive Summary
Director Kevin K. Gordon filed a Form 144 notice of intent to sell 5,500 shares of Progyny (PGNY) at an estimated aggregate market value of $137,445. The shares were acquired via restricted stock vesting on May 22, 2026, and the sale is for compensation-related purposes. This is a routine insider sale by a director, not an executive officer, and represents a small fraction of the company's $2.0B market cap.
Key Facts
- Director Kevin K. Gordon filed Form 144 to sell 5,500 shares of PGNY common stock.
- Estimated aggregate market value of the proposed sale is $137,445.
- Shares were acquired via restricted stock vesting on May 22, 2026.
- The sale is for compensation-related purposes, not a discretionary open-market sale.
- Gordon is a director, not an executive officer (CEO/CFO), reducing signaling weight.
- The proposed sale represents ~0.18% of the company's $2.0B market cap.
- No other insider sales or purchases in the prior 30 days were reported.
Financial Impact
Proposed sale of 5,500 shares worth ~$137,445, negligible relative to $2.0B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Director sales carry less signaling weight than C-suite sales.
- No other insider activity to corroborate a bearish thesis.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004031 |
| Document: 0001959173-26-004031-index.html | 0001959173-26-004031 |
| Document: 0001959173-26-004031.txt | 0001959173-26-004031 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 144 | $27.08 $27.01 | ▼ −0.26% | ▲ +0.24% | $25.23 (−6.83%) |
Jul 23, 2026 10w ago | Press Release | $30.70 $31.49 | ▲ +2.57% | ▲ +2.10% | $25.23 (−17.82%) |
Jun 12, 2026 16w ago | Institutional Cluster | $26.63 $26.08 | ▲ +2.07% | ▲ +2.74% | $25.23 (+5.26%) |
Jun 3, 2026 17w ago | Insider Cluster | $25.48 $25.65 | ▲ +0.67% | ▲ +3.22% | $25.23 (−0.98%) |
Jun 3, 2026 17w ago | Insider Cluster | $25.48 $25.65 | ▲ +0.67% | ▲ +3.22% | $25.23 (−0.98%) |
May 28, 2026 18w ago | Press Release | $25.69 $24.99 | ▲ +2.72% | ▲ +2.68% | $25.23 (+1.79%) |
May 27, 2026 18w ago | 144 | $25.48 $25.12 | ▼ −1.41% | ▼ −2.62% | $25.23 (−0.98%) |
May 26, 2026 18w ago | 8-K | $25.05 $26.20 | ▲ +4.59% | ▲ +3.51% | $25.23 (+0.72%) |
May 21, 2026 19w ago | Insider Cluster | $24.88 $26.20 | ▲ +5.31% | ▲ +3.63% | $25.23 (+1.41%) |
May 21, 2026 19w ago | Insider Cluster | $24.88 $26.20 | ▲ +5.31% | ▲ +3.65% | $25.23 (+1.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access